ESTRO 35 Programme book

MONDAY 2 MAY 2016

Medical oncologist Panellist: M. Di Maio (Italy) Interventional radiologist Panellist: A. Veltri (Italy) Thoracic surgeon Panellist: E. Ruffini (Italy)

Symposium DOSE PAINTING: THOSE PENDING ISSUES 16:45 - 17:45 | ROOM 2

Dose painting is the delivery of a non-uniform dose distribution according to a spatial distribution of a given phenotype of the tumour volume, supposedly provided by functional imaging (PET, MR...). Such strategy would enable tailored dose escalation/redistribution in radio resistant regions of the tumour volume, mitigating toxicity issues that would originate from a flat, homogeneous dose escalation. Although conceptually appealing and relatively simple in its formulation, a dose painting treatment strategy involves a complex chain of technical steps with uncertainties that could ultimately make the delivered dose distribution unrepresentative of the actual biology of the tumour. In this symposium, we will first define the biological and clinical rationale supporting the dose painting concept before covering the challenges to be solved before a meaningful clinical implementation.

Chair: E. Sterpin (Belgium) Co-chair: P. Franco (Italy)

16:45 > The promises of dose painting Speaker: W. De Neve (Belgium)

SP-0520

17:05 > The biological rationale of dose painting: is it realistic? Speaker: M. Alber (Denmark)

SP-0521

17:25 > Dose prescription and treatment delivery at the voxel scale: a fantasy? Speaker: J. Lee (Belgium)

SP-0522

Symposium

ACROP 16:45 - 17:45 | ROOM 4

Since 2012 the Advisory Committee for Radiation Oncology Practice (ACROP) has taken over the re- sponsibility for the initiation and coordination of ESTRO internal guidelines ae well as multidisciplinary guidelines together with other scientific societies. During this ESTRO 35 ACROP session C. Belka will present the workflow and SOP of ACROP; K. Tanderup will give a brief overview of the ongoing and mature guidelines in the areas of brachtherapy and physics; and, M. Niyazi will present the new guideline on 'Target volume delineation in Glioblas- toma'.

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

141